Future of Precision Medicine Symposium 2022
As part of the Novo Nordisk Foundation’s precision medicine initiatives, the two-day Future of Precision Medicine Symposium 2021 featured lectures and panel discussions on within a broad array – from major innovations in precision diabetes medicine to cutting-edge research through clinical implementation.
The discovery of insulin 100 years ago was a true breakthrough and lifesaver in the treatment of people with diabetes. However, despite being around for a century, insulin and other means of treatment, often deployed in a one-size-fits-all manner, still fail to take most people to a level of control that normalizes morbidity and mortality. Precision medicine, the tailoring of disease prevention and treatment strategies based on an individual’s genetics and other biomarkers, lifestyle and environment, aims at doing just that, by helping optimise medical decisions.
The symposium also celebrated the winner of the EFSD and Novo Nordisk Foundation Precision Diabetes Medicine Award. The award honours innovative research in both clinical and basic science that is likely to minimise the future burden of diabetes and other chronic disease.
See the full programme for the Future Precision Medicine Symposium 2022 here.
Thursday, 17 November
Official opening
Welcome and opening remarks
By Senior Vice President Martin Ridderstråle, the Novo Nordisk Foundation &
President Stefano Del Prato, the European Foundation for the Study of Diabetes
Click here
Diabetes: the lived experience. Why the promise of precision diabetes medicine really matters
Panelists:
- Persons with diabetes Christian Collin, Steno Diabetes Center Copenhagen (DK)
- Persons with diabetes Sophie Hindkjær, Steno Diabetes Center Copenhagen (DK)
- Mother to a person with type 1-diabetes and a nurse specialist Maria Tørnes, Steno Diabetes Center Zealand (DK)
Facilitated by: Senior Vice President Martin Ridderstråle, the Novo Nordisk Foundation (DK)
Translating precision medicine research into clinical practice
Lecture by Scientific Director, Professor Paul Franks, Novo Nordisk Foundation (DK)
Click here
Theme I: Real world impressions on Precision Medicine
Role of Precision Nutrition in the dietary management of diabetes
Lecture by Professor Gary Frost, Imperial College London (UK)
Click here
Precision Diabetes Medicine: Evolution not Revolution
Lecture by Adjunct Professor John Nolan, Trinity College Dublin (IE)
Click here
Q&A
Facilitated by Senior Vice President Martin Ridderstråle, the Novo Nordisk Foundation
Click here
Theme II: Trans-ethnic perspective on Precision Medicine
The many faces of diabetes
Lecture by Dr Shivani Misra, Faculty of Medicine, Imperial College London (UK)
Click here
Why diversity matters in precision medicine
Lecture by Professor K. Venkat Narayan, Emory University (US)
Click here
Q&A
Facilitated by Professor Torben Hansen, Novo Nordisk Foundation Center for Basic Metabolic Research (DK)
Click here
Theme III: Clinical Translation
Precision diabetes medicine: getting to the heart of the matter
Lecture by Professor Guillaume Paré, Pathology & Molecular Medicine, McMaster University (CA)
Click here
Clinical readiness of precision diabetes medicine
Lecture by Professor Tina Vilsbøll, Steno Diabetes Center Copenhagen (DK)
Click here
A global perspective on precision diabetes medicine in practice: where next?
Lecture by Director Dr. William T. Cefalu, the Division of Diabetes, Endocrinology and Metabolic Diseases at the National Institute of Diabetes, Digestive and Kidney Diseases (US)
Click here
Q&A
Facilitated by Professor Isabel Goncalves, Lund University (S)
Click here
Award Ceremony: THE EFSD and the Novo Nordisk Foundation Precision Diabetes Medicine Award 2022
Opening remarks by chair: Professor Coen D.A. Stehouwer, Chairperson EFSD Scientific Board (DE)
Click here
Understanding biomarker predictors of differential response to oral glucose lowering therapies in the TRIMASTER crossover trial
Prize Lecture by Associate Professor Angus Jones, University of Exeter (UK)
Click here
Friday, 18 November
Runner-up Awardees
Proteomics in precision medicine to identify novel therapeutic targets for depressive symptoms in individuals newly diagnosed with diabetes
Runner-up lecture by Dr. Dr. Haifa Maalmi, German Diabetes Center (D)
Click here
Exercise and insulin action – when it gets personal(ized)
Runner-up lecture by Professor Jørgen Wojtaszewski, University of Copenhagen (DK)
Click here
Theme IV: The ADA/EASD Precision Diabetes Medicine Initiative
Overview of the ADA/EASD Precision Diabetes Medicine Initiative
Lecture by Professor Ruth Loos, Novo Nordisk Foundation Center for Basic Metabolic Research (DK)
Click here
The evidence for precision prognostics in diabetes
Lecture by Professor Ronald Ma, The Chinese University of Hong Kong (HK)
Click here
Q&A
Facilitated by Scientific Director, Professor Paul Franks, Novo Nordisk Foundation (DK)
Click here
Debate: Precision medicine: deal or no deal?
Panelists:
- Professor Allan Vaag, Lund University (S)
- Professor Elisabeth Selvin, Johns Hopkins University (US)
- Ebba Carbonnier, MSc MBA, Portfolio Manager Swelife and Director Quantum Life Science Centre at Karolinska Institutet (S)
- Professor Chantal Mathieu, KULeuven (BE)
Facilitated by Professor Juleen Zierath, Novo Nordisk Foundation Center for Basic Metabolic Research (DK), Karolinska Institutet (S)
Click here
Theme V: Precision medicine and AI
Precision Medical Robotics and AI
Lecture by Professor Thiusius Rajeeth Savarimuthu, SDU Robotics, University of Southern Denmark (DK)
Click here
Early pathophysiology-based subphenotyping before diabetes manifestation to prevent complications
Lecture by Professor Robert Wagner, Heinrich Heine University Düsseldorf (DE)
Click here
Q&A
Facilitated by Scientific Director, Professor Paul Franks, Novo Nordisk Foundation (DK)
Click here
Official closing
Closing remarks
By Senior Vice President Martin Ridderstråle, the Novo Nordisk Foundation &
President Stefano Del Prato, the European Foundation for the Study of Diabetes
Click here
